WAM
BJDX icon

Warberg Asset Management’s Bluejay Diagnostics BJDX Stock Holding History

Warberg Asset Management’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-63
Closed -$8.74K – 216
2024
Q2 		$8.74K Buy
+63
New +$52.9K ﹤0.01% 179

Other funds holding BJDX

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Warberg Asset Management's BJDX Position: Q3 2024 in Review

Warberg Asset Management sold out of Bluejay Diagnostics (BJDX) in Q3 2024, closing a stake of 63 shares — an estimated $8.74K sold.

Warberg Asset Management first reported a position in BJDX in Q2 2024 and held it in 1 quarter. The position peaked at $8.74K in Q2 2024. 11 funds tracked by Wall St. Rank hold BJDX as of Q3 2024.

  • Warberg Asset Management reported no remaining Bluejay Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Warberg Asset Management sold 63 Bluejay Diagnostics shares in Q3 2024, an estimated $8.74K.
  • Warberg Asset Management first reported a position in Bluejay Diagnostics in Q2 2024 and held it in 1 quarter.
  • Warberg Asset Management's Bluejay Diagnostics position peaked at $8.74K in Q2 2024.
  • 11 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2024.

Based on Warberg Asset Management's 13F filing for Q3 2024, filed 6 Nov 2024.